Physician Specializing in Rare Diseases Sought by State Agency

March 28, 2024

The Minnesota Rare Disease Advisory Council (RDAC) is looking for a physician licensed and practicing in the state with experience researching, diagnosing, or treating rare diseases. The three-year term begins in January 2025. 

RDAC is an executive branch state agency whose purpose is to improve care for the one in 10 Minnesotans living with a rare disease. RDAC is charged with the following:  

  • provide advice on policies, access, equity, research, diagnosis, treatment, and education related to rare diseases.  

  • provide resources, identifying and recommending best practices, identifying and addressing barriers faced by rare disease patients. 

  • advise agencies of state government on policies related to rare diseases. 

RDAC holds hybrid bimonthly meetings in January, March, May, July, September and November. In addition, all members are encouraged to serve on at least one working group/committee, which meets monthly.  

Interested candidates can apply on the Secretary of State, Boards and Commissions Website: Open Positions Search (state.mn.us) 

For more information, visit the RDAC website and/or contact the Executive Director Erica Barnes at erica.barnes@state.mn.us. 

Latest News

Physician/Olympian to Give Inspirational Address at Empowering Physicians Event

August 20, 2026

A physician and Olympian will give an inspirational address as part of this year's Empowering Physicians event on Friday, September 25, at the Minneapolis Institute of Art.

Minnesota Vaccination Rates Trending in Wrong Direction

August 20, 2026

Minnesota received some disturbing news this week from the Centers for Disease Control and Prevention (CDC), as data shows that for the 2025-2026 school year, vaccination rates decreased and non-medical exemptions increased.  

Appellate Court Sides with Texas Medical Association in No Suprises Act Lawsuit

August 20, 2026

On August 11, a federal appellate court sided with the Texas Medical Association (TMA) argument that the way the No Surprises Act’s qualifying payment amount (QPA) is calculated has historically favored payers in arbitration.